Why it matters
The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
Project record
At a glance
- Company
- PCI Pharma Services
- Industry
- Pharmaceuticals
- Location
- Bedford, New Hampshire
- Investment
- $100.0M
- Permanent jobs announced
- 150
- Status
- Operational
- Announced
- May 10, 2022
- Operations began
- Date not publicly specified
- Added to tracker
- Aug 14, 2026
Sources
Official references
- Original company announcement https://pci.com/news/major-manufacturing-expansion-with-100-million-investment-in-bedford-new-hampshire-campus
- Operational campus and inspection evidence https://pci.com/news/pci-bedford-location-successfully-completes-icmra-inspection
- Supporting project and job evidence https://www.pharmaceutical-technology.com/projects/pcis-site-expansion-bedford/
Related
Other projects to know
In New Hampshire
Back to the tracker/projects/pci-pharma-services-bedford-sterile-manufacturing-expansion